Jeena Sikho Lifecare Limited has informed the Exchange about Publication of case studies and case reports.
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jeena Sikho Lifecare has informed the stock exchanges about three academic publications — two case studies and one case report — focused on managing Chronic Kidney Disease (CKD) using Ayurvedic therapies. The papers appeared in the International Journal of Ayurveda and Herbal Research and the Journal of Applied Science and Education. They were co-authored by Managing Director Acharya Manish Grover along with several company doctors and Ayurvedic experts. The case studies describe kidney function improvements in patients treated at the company's hospitals, such as serum creatinine dropping from 6.32 to 5.17 mg/dL and blood urea falling from 230.86 to 117.39 mg/dL in one case. The company describes this as part of its commitment to evidence-based Ayurvedic research.
This is a routine academic/research disclosure and does not directly affect revenue, orders, or financial guidance. It may provide modest brand-building value by showcasing clinical outcomes for the company's Ayurvedic kidney-care treatments.